Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

    Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    Start listeningView podcast show

    Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    ratings:
    Length:
    18 minutes
    Released:
    Jan 3, 2024
    Format:
    Podcast episode

    Description

    Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies mean for future of type 1 diabetes management.

    Episode Highlights
    00:05 Intro
    01:20 Baricitinib Overview
    02:30 BANDIT Trial Design
    03:30 Trial Results
    05:40 Delaying Type 1 Diabetes
    14:45 Need for Screening
    18:00 Outro
    Released:
    Jan 3, 2024
    Format:
    Podcast episode

    Titles in the series (94)

    Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at http://HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.